Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,044,000 | 878,000 | 945,000 | 739,000 | 686,000 |
Receivables | 1,827,000 | 1,675,000 | 1,677,000 | 1,819,000 | 1,787,000 |
Inventories | 1,400,000 | 1,327,000 | 1,336,000 | 1,417,000 | 1,331,000 |
Other current assets | 578,000 | 522,000 | 485,000 | 495,000 | 470,000 |
TOTAL | $4,849,000 | $4,402,000 | $4,443,000 | $4,470,000 | $4,274,000 |
Non-Current Assets | |||||
PPE Net | 3,702,000 | 3,668,000 | 3,615,000 | 3,831,000 | 3,734,000 |
Intangibles | 4,081,000 | 3,998,000 | 4,118,000 | 4,377,000 | 3,243,000 |
Other Non-Current Assets | 622,000 | 656,000 | 592,000 | 566,000 | 680,000 |
TOTAL | $8,405,000 | $8,322,000 | $8,325,000 | $8,774,000 | $7,657,000 |
Total Assets | $13,254,000 | $12,724,000 | $12,768,000 | $13,244,000 | $11,931,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 334,000 | 346,000 | 921,000 | 953,000 | 597,000 |
Accounts payable and accrued liabilities | 1,187,000 | 1,244,000 | 1,150,000 | 1,236,000 | 1,181,000 |
TOTAL | $4,107,000 | $3,716,000 | $4,317,000 | $4,249,000 | $4,282,000 |
Non-Current Liabilities | |||||
Long Term Debt | 4,595,000 | 4,430,000 | 3,768,000 | 4,020,000 | 3,166,000 |
aiOther Non-Current Liabilities | 1,768,000 | 1,750,000 | 1,505,000 | 1,627,000 | 1,702,000 |
TOTAL | $6,651,000 | $6,467,000 | $5,581,000 | $5,851,000 | $5,058,000 |
Total Liabilities | $10,758,000 | $10,183,000 | $9,898,000 | $10,100,000 | $9,340,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 954,493 | 959,155 | 967,999 | 972,992 | 977,788 |
Common Shares | 733,000 | 733,000 | 733,000 | 733,000 | 733,000 |
Retained earnings | 15,670,000 | 15,649,000 | 15,344,000 | 14,983,000 | 14,360,000 |
Other shareholders' equity | -2,104,000 | -2,369,000 | -2,055,000 | -1,653,000 | -1,848,000 |
TOTAL | $2,496,000 | $2,541,000 | $2,870,000 | $3,144,000 | $2,591,000 |
Total Liabilities And Equity | $13,254,000 | $12,724,000 | $12,768,000 | $13,244,000 | $11,931,000 |